Darwin Biotech Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
19
- Latest Deal Type
-
PE Growth
- Financing Rounds
-
8
Darwin Biotech General Information
Description
Developer of a point-of-care diagnostic platform designed for early infection identification. The company's self-contained diagnostic device utilizes saliva-based sampling and host-response biomarker panels to detect immune signatures, enabling healthcare providers to access rapid results without laboratory infrastructure or external power sources.
Contact Information
Website
www.darwinbio.techCorporate Office
- Building B, Liugonghui, Shougang Park
- Shijingshan District
- Beijing
- China
Corporate Office
- Building B, Liugonghui, Shougang Park
- Shijingshan District
- Beijing
- China
Darwin Biotech Timeline
Darwin Biotech Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Darwin Biotech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Darwin Biotech Patents
Darwin Biotech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026017015-A1 | Protein polymer and production process therefor | Pending | 19-Mar-2024 | ||
| WO-2026017018-A1 | Protein polymer and use thereof in treatment of alzheimer's disease | Pending | 19-Mar-2024 | ||
| WO-2026017019-A1 | Protein polymer and use thereof in treatment of spinocerebellar ataxia disease | Pending | 19-Mar-2024 | ||
| WO-2026017016-A1 | Quality detection method for protein polymer | Pending | 19-Mar-2024 | ||
| WO-2026017017-A1 | Use of protein polymer in treatment of amyotrophic lateral sclerosis | Pending | 19-Mar-2024 | A61K38/385 |
Darwin Biotech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Darwin Biotech Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Darwin Biotech FAQs
-
When was Darwin Biotech founded?
Darwin Biotech was founded in 2016.
-
Where is Darwin Biotech headquartered?
Darwin Biotech is headquartered in Beijing, China.
-
What is the size of Darwin Biotech?
Darwin Biotech has 19 total employees.
-
What industry is Darwin Biotech in?
Darwin Biotech’s primary industry is Drug Discovery.
-
Is Darwin Biotech a private or public company?
Darwin Biotech is a Private company.
-
What is Darwin Biotech’s current revenue?
The current revenue for Darwin Biotech is .
-
How much funding has Darwin Biotech raised over time?
Darwin Biotech has raised $69.7M.
-
Who are Darwin Biotech’s investors?
Fujian Huamin Lianxin Private Equity Fund Management, Taiping Guofa Hehe (Beijing) Investment Management, Beijing Shijingshan District State-owned Capital Investment, THG Ventures, and Red Star Macalline are 5 of 6 investors who have invested in Darwin Biotech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
